Tempest Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tempest Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2013 to Q3 2024.
  • Tempest Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 127 %, a 60.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 127 -193 -60.3% Sep 30, 2024
Q2 2024 157 -34.6 -18.1% Jun 30, 2024
Q1 2024 194 +54.2 +38.7% Mar 31, 2024
Q4 2023 246 +119 +93.8% Dec 31, 2023
Q3 2023 320 +204 +176% Sep 30, 2023
Q2 2023 191 -45.6 -19.2% Jun 30, 2023
Q1 2023 140 -39.4 -21.9% Mar 31, 2023
Q4 2022 127 +503 Dec 31, 2022
Q3 2022 116 +183 Sep 30, 2022
Q2 2022 237 +284 Jun 30, 2022
Q1 2022 179 +202 Mar 31, 2022
Q4 2021 -377 -362 -2524% Dec 31, 2021
Q3 2021 -67.4 -47.4 -238% Sep 30, 2021
Q2 2021 -46.7 -1.84 -4.1% Jun 30, 2021
Q1 2021 -22.2 +609 +96.5% Mar 31, 2021
Q4 2020 -14.4 -63.5 -129% Dec 31, 2020
Q3 2020 -19.9 -41.2 -194% Sep 30, 2020
Q2 2020 -44.9 -61.9 -364% Jun 30, 2020
Q1 2020 -631 -645 -4699% Mar 31, 2020
Q4 2019 49.1 +37.4 +317% Dec 31, 2019
Q3 2019 21.2 -71.5 -77.1% Sep 30, 2019
Q2 2019 17 -35.1 -67.3% Jun 30, 2019
Q1 2019 13.7 -27.5 -66.7% Mar 31, 2019
Q4 2018 11.8 -21.4 -64.5% Dec 31, 2018
Q3 2018 92.7 +79.1 +583% Sep 30, 2018
Q2 2018 52.1 +39.7 +321% Jun 30, 2018
Q1 2018 41.2 +30.7 +291% Mar 31, 2018
Q4 2017 33.1 +22.5 +213% Dec 31, 2017
Q3 2017 13.6 +3.88 +40% Sep 30, 2017
Q2 2017 12.4 +3.34 +37% Jun 30, 2017
Q1 2017 10.6 +2.53 +31.5% Mar 31, 2017
Q4 2016 10.6 +4.47 +73.1% Dec 31, 2016
Q3 2016 9.7 +3.03 +45.5% Sep 30, 2016
Q2 2016 9.02 +1.56 +20.9% Jun 30, 2016
Q1 2016 8.03 -0.83 -9.37% Mar 31, 2016
Q4 2015 6.12 -5.17 -45.8% Dec 31, 2015
Q3 2015 6.66 -3.58 -35% Sep 30, 2015
Q2 2015 7.46 -0.97 -11.5% Jun 30, 2015
Q1 2015 8.86 +1.84 +26.2% Mar 31, 2015
Q4 2014 11.3 +5.41 +92.1% Dec 31, 2014
Q3 2014 10.2 +5.97 +140% Sep 30, 2014
Q2 2014 8.43 +3.98 +89.5% Jun 30, 2014
Q1 2014 7.02 +0.2 +2.93% Mar 31, 2014
Q4 2013 5.88 Dec 31, 2013
Q3 2013 4.27 Sep 30, 2013
Q2 2013 4.44 Jun 30, 2013
Q1 2013 6.82 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.